Advertisement
New Zealand markets closed
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NZD/USD

    0.5986
    +0.0010 (+0.17%)
     
  • NZD/EUR

    0.5544
    +0.0011 (+0.20%)
     
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,369.44
    +201.37 (+0.50%)
     
  • NZD/JPY

    90.4570
    +0.0640 (+0.07%)
     

Datacubed Health Announces New Board Member, Mark Blumling

Leading Life Sciences and Biopharmaceutical Executive Joins Board of Directors, Bringing Extensive Industry Experience and Entrepreneurial Spirit

New York, New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Datacubed Health, a leading eClinical technology company, is proud to announce the appointment of Mark Blumling to its Board of Directors.

Mark brings a wealth of experience from the life sciences and biotechnology industries, most recently as CEO, President, and Founder at Headlands Research, an international clinical trial site organization.  He has devoted his career to improving population health and patient outcomes. Mark’s career began at SmithKline Beecham, where he was involved with creating and developing new business ventures. Subsequently, Mark was the Founder and COO of Hyperion Therapeutics, CEO of Relevare Pharmaceuticals, and CEO and Co-Founder of Genos.

“We are thrilled to welcome Mark to our Board,” said Brett Kleger, CEO of Datacubed Health. “His expertise in the life sciences, big data, and biotechnology, coupled with his passion for improving patient outcomes, make him a valuable addition to our team as we continue to innovate and drive growth.”

ADVERTISEMENT

Having held leadership positions at several healthcare, life sciences, and pharmaceutical organizations, Mark deeply understands the challenges and opportunities in these industries. He is excited to bring his experience and insights to Datacubed Health and help the company continue to make a positive impact on the healthcare industry.

“I am honored to join the Datacubed Health team and am excited to contribute my experience and insights to the company’s mission of advancing access to healthcare through innovative clinical technology solutions,” said Mark Blumling.

About Datacubed Health

Datacubed Health is a pioneering patient engagement and data collection company dedicated to advancing access to healthcare for everyone, everywhere. Datacubed applies individualized smartphone solutions for the capture of ePRO and eCOA data, passive data collection, instrument delivery, wearables, and environmental sensors. Focusing on life sciences, Datacubed Health offers software and services based on behavioral science to improve patient retention and compliance, resulting in better patient outcomes and more rewarding clinical experiences.

For more information, please visit www.datacubed.com

CONTACT: Jillian Tygh Datacubed Health 2672543997 jillian.tygh@datacubed.com